Meeting
2012 Genitourinary Cancers Symposium
Meta-analysis of randomized control trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
Authors
Christopher J. Richards
Beth Israel Deaconess Medical Center, Boston, MA
Christopher J. Richards , Youjin Je , Fabio A. B. Schutz , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session E: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 349)
DOI
10.1200/jco.2012.30.5_suppl.349
Abstract #
349
Poster Bd #
A2
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
First Author: Daniel Vargas Almeida
Poster
2019 ASCO Annual Meeting
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
First Author: Daniel Vargas Almeida
Poster
2018 ASCO Annual Meeting
A meta-analysis of randomized controlled trials for efficacy and safety of vascular endothelial growth factor tyrosine kinase inhibitors (VEGF-TKIs) adjuvant therapy in high-risk renal cell cancer (RCC).
First Author: Irbaz Bin Riaz
Poster
2018 Genitourinary Cancers Symposium
Adjuvant antiangiogenic agents in post-nephrectomy renal cell carcinoma (RCC): A systematic review and meta-analysis.
First Author: Mohamad Bassam Sonbol